Consensus Estimates and Trading Data for Corcept Therapeutics Incorporated (CORT)

In the past 52-week period, shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) have moved within the range of $6.70 to $20.77. On the stock’s most recent trading day, the company’s shares ended the regular session at $17.58, which is 15.36% lower than its 52-week high.

Corcept Therapeutics Incorporated (CORT) has demonstrated a 20-day simple moving average (SMA) of -4.33%, and a 50-day SMA of -5.62%. This public company’s current market capitalization stands at $2.08 billion.

Analyzing Consensus Estimates, Sales Revenue and Net Income

Checking the amount of enthusiasm that Wall Street analysts hold for a particular stock is crucial when thinking about entering a position. According to the latest data, the consensus recommendation for Corcept Therapeutics Incorporated (CORT) is Hold.

Public companies normally post earnings and revenue results that fall somewhat above or below the average Wall Street estimate. In the most recent quarterly financial report, for the quarter ending Sep. 2017, Corcept Therapeutics Incorporated (CORT) delivered a 0.71% surprise with its net revenue. Sales reached $0.04 billion during the three-month period, compared to the average analyst estimate of $0.04 billion.

Ownership at Corcept Therapeutics Incorporated (CORT), According to Most Recent SEC Filings

A publicly-traded organization’s latest 13F filings tell us important details about its institutional ownership. Corcept Therapeutics Incorporated (CORT) has 0 billion shares outstanding currently, 64.72% of which belong to institutional investors. Those institutional holdings amount to $1.26 billion.

Additionally, according to the most recent 13F filing from Corcept Therapeutics Incorporated (CORT), there were 47 new positions totaling 2,917,225 shares of the company’s stock. There were 14 sold out positions, on the other hand, totaling 726,055 shares.

Short, Medium and Long Term Indicators

Assessing the average trade volume of a public company’s stock in the short, medium and long term is helpful to gain an understanding of trading activity and investor sentiment. Corcept Therapeutics Incorporated (CORT) has had a 20-day average volume of 1,343,535 shares, with an average of 80% of short term indicators pointed at Sell.

The stock’s 50-day average volume has been 1,475,224 shares, with an average of 0% of medium term indicators pointing toward Hold. Finally, its 100-day average volume is 1,320,385 shares with 67% of long-term indicators pointing to Buy.